Maple Cross Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 23 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.57 Cr
- Satisfied Charges ₹ 3.26 Cr
- Revenue Growth -0.05%
- Profit Growth 4.54%
- Ebitda 50.42%
- Net Worth 17.62%
- Total Assets -0.18%
About Maple Cross Remedies
Maple Cross Remedies Private Limited (MCRPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 12 June 2001 and has a history of 23 years and eight months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.57 Cr. The company has closed loans amounting to ₹3.26 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anuj Shahani, Mahesh Bakhru, Jaikishan Shahani, and Three other members serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85199MH2001PTC132312
-
Company No.
132312
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Jun 2001
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Maple Cross Remedies?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anuj Shahani
|
Director | 16-Aug-2005 | Current |
|
Mahesh Bakhru
|
Director | 12-Jun-2001 | Current |
|
Jaikishan Shahani
|
Director | 12-Jun-2001 | Current |
|
Deepika Shahani
|
Director | 26-May-2015 | Current |
|
Roma Bakhru
|
Director | 26-May-2015 | Current |
|
Usha Shahani
|
Director | 26-May-2015 | Current |
Financial Performance of Maple Cross Remedies.
Maple Cross Remedies Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.05% decrease. The company also saw a slight improvement in profitability, with a 4.54% increase in profit. The company's net worth Soared by an impressive increase of 17.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maple Cross Remedies?
In 2023, Maple Cross Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Mapcon Meditech Private LimitedAnuj Shahani and Mahesh Bakhru are mutual person
-
Liricon Trading Private Limited
Anuj Shahani, Mahesh Bakhru and 4 more are mutual person
Charges (Loans)
₹15.68 M
₹32.58 M
Charges Breakdown by Lending Institutions
- Others : 1.01 Cr
- Hdfc Bank Limited : 0.41 Cr
- Corporation Bank : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Mar 2024 | Hdfc Bank Limited | ₹2.58 M | Open |
| 03 Mar 2022 | Hdfc Bank Limited | ₹1.50 M | Open |
| 30 Jun 2021 | Others | ₹1.01 Cr | Open |
| 12 Jan 2005 | Corporation Bank | ₹1.50 M | Open |
| 12 May 2021 | Others | ₹2.70 Cr | Satisfied |
How Many Employees Work at Maple Cross Remedies?
Unlock and access historical data on people associated with Maple Cross Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maple Cross Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maple Cross Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.